
UnitedHealth Group, Intuitive Surgical, Johnson & Johnson, Hims & Hers Health, and Globus Medical are the five Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares of companies operating in the healthcare sector—including pharmaceuticals, biotechnology, medical device makers, hospitals and clinics, health insurers, and related service providers. Investors view them based on factors like drug approvals, clinical trial results, regulatory and reimbursement environments, patents, and demographic demand for medical care. These stocks can offer a mix of defensive income and growth potential but carry sector-specific risks such as clinical failures and regulatory setbacks. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Intuitive Surgical (ISRG)
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read Our Latest Research Report on ISRG
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Read Our Latest Research Report on JNJ
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Read Our Latest Research Report on HIMS
Globus Medical (GMED)
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.
Read Our Latest Research Report on GMED
Featured Articles
- MarketBeat’s Top Five Stocks to Own in November 2025
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
- Qualcomm Earnings Surprise Wall Street—Here’s What Q4 Could Deliver
- MarketBeat Week in Review – 11/03 – 11/07
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
